Literature DB >> 18226043

The expression of TNF-alpha converting enzyme at the site of ruptured plaques in patients with acute myocardial infarction.

M Satoh1, Y Ishikawa, T Itoh, Y Minami, Y Takahashi, M Nakamura.   

Abstract

BACKGROUND: Tumour necrosis factor-alpha (TNF-alpha) converting enzyme (TACE) plays an essential role in the TNF-alpha shedding process, which could affect the outcome of acute myocardial infarction (AMI). However, it remains unclear whether it originates from the ruptured plaque or represents a systemic process. This study analysed TACE-mediated TNF-alpha shedding at the site of ruptured plaques in AMI patients and compared them with a systemic mechanism.
MATERIALS AND METHODS: The study included 60 patients with AMI who underwent percutaneous coronary intervention (PCI) and 21 patients with stable angina pectoris (SA). Local samples from the site of plaque were taken from AMI using aspiration catheter treatment. Systemic samples were also taken from the aorta in all patients with AMI and SA.
RESULTS: Systemic levels of TACE and TNF-alpha were higher in AMI patients than in SA patients. In AMI patients, these levels were higher in local samples than in systemic samples. A positive correlation was seen between local TACE and TNF-alpha levels in AMI patients. Thrombus material removed from the ruptured plaque showed immunostainings of TACE and TNF-alpha in infiltrating macrophages. By six months follow-up study, local TACE levels remained the only significant independent predictors of adverse cardiac events in AMI patients.
CONCLUSIONS: This study demonstrates that local expression of TACE is related to TNF-alpha shedding at the site of ruptured plaques in AMI patients. In addition, local TACE expression at the site of ruptured plaques may play an important role in poor outcomes in patients with AMI.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18226043     DOI: 10.1111/j.1365-2362.2007.01912.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  19 in total

Review 1.  Cell Death in the Vessel Wall: The Good, the Bad, the Ugly.

Authors:  Katey J Rayner
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-07       Impact factor: 8.311

Review 2.  ADAM-17: the enzyme that does it all.

Authors:  Monika Gooz
Journal:  Crit Rev Biochem Mol Biol       Date:  2010-04       Impact factor: 8.250

3.  Systems analysis of gene ontology and biological pathways involved in post-myocardial infarction responses.

Authors:  Nguyen T Nguyen; Merry L Lindsey; Yu-Fang Jin
Journal:  BMC Genomics       Date:  2015-06-11       Impact factor: 3.969

Review 4.  Macrophage Trafficking, Inflammatory Resolution, and Genomics in Atherosclerosis: JACC Macrophage in CVD Series (Part 2).

Authors:  Kathryn J Moore; Simon Koplev; Edward A Fisher; Ira Tabas; Johan L M Björkegren; Amanda C Doran; Jason C Kovacic
Journal:  J Am Coll Cardiol       Date:  2018-10-30       Impact factor: 24.094

5.  Rapid and sensitive detection of the activity of ADAM17 using a graphene oxide-based fluorescence sensor.

Authors:  Youwen Zhang; Xiaohan Chen; Golbarg M Roozbahani; Xiyun Guan
Journal:  Analyst       Date:  2019-02-25       Impact factor: 4.616

6.  A disintegrin and metalloprotease 17 mediates neointimal hyperplasia in vasculature.

Authors:  Akira Takaguri; Keita Kimura; Akinari Hinoki; Allison M Bourne; Michael V Autieri; Satoru Eguchi
Journal:  Hypertension       Date:  2011-02-28       Impact factor: 10.190

Review 7.  Immune modulation: role of the inflammatory cytokine cascade in the failing human heart.

Authors:  Mamoru Satoh; Yoshitaka Minami; Yuji Takahashi; Motoyuki Nakamura
Journal:  Curr Heart Fail Rep       Date:  2008-06

8.  Neutrophil and Macrophage Cell Surface Colony-Stimulating Factor 1 Shed by ADAM17 Drives Mouse Macrophage Proliferation in Acute and Chronic Inflammation.

Authors:  Jingjing Tang; Jeremy M Frey; Carole L Wilson; Angela Moncada-Pazos; Clémence Levet; Matthew Freeman; Michael E Rosenfeld; E Richard Stanley; Elaine W Raines; Karin E Bornfeldt
Journal:  Mol Cell Biol       Date:  2018-08-15       Impact factor: 4.272

Review 9.  Contribution of ADAM17 and related ADAMs in cardiovascular diseases.

Authors:  Tatsuo Kawai; Katherine J Elliott; Rosario Scalia; Satoru Eguchi
Journal:  Cell Mol Life Sci       Date:  2021-02-11       Impact factor: 9.207

10.  Cardiovascular effects of tumour necrosis factor α antagonism in patients with acute myocardial infarction: a first in human study.

Authors:  Gareth J Padfield; Jehangir N Din; Elena Koushiappi; Nicholas L Mills; Simon D Robinson; Nicholas Le May Cruden; Andrew John Lucking; Stanley Chia; Scott A Harding; David E Newby
Journal:  Heart       Date:  2013-04-10       Impact factor: 7.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.